Company presents second generation device for treating wounds
- Wed, 6/23/10 - 11:39am
- 0 Comments
- 965 reads
NanoVibronix (Nesher, Israel), a medical device company which develops innovative therapeutic ultrasound applications, announced that following its initial success with the first generation PainShield™device for pain therapy, especially for the severe pain associated with Trigeminal Neuralgia, NanoVibronix recently launched its second generation PainShield with additional features for the therapy of chronic pain and wounds. PainShield is a small, portable device that produces low frequency, low intensity ultrasonic waves for the healing of soft tissue such as tendon, chronic wounds and neuropathic pain.
![]()
The device is comprised of two parts, a small electronic device, which produces electrical signals and a therapeutic patch containing a thin ultrasound transducer which is placed on or near the intended area of therapy. The device is battery powered and allows patients to ambulate while receiving therapy. The device is approved by the Israeli Ministry of Health and has CE Mark. It is cleared by the FDA for treatment of pain.
NanoVibronix also presented at BioMed 2010, a new application for advanced wound care treatment. The WoundShield patches allow localized therapy of wounds by enhanced penetration of antibiotics and/or oxygen into the wound bed. NanoVibronix is collaborating with Trinity Wound Institute (Raleigh, NC) that is developing SonOx Therapy for localized oxygen delivery to wounds.
For more information, visit www.nanovibronix.com.





